Track CureVac N.V.'s operating income ($210M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Nov 30, 2025
Trailing 12 months ending Nov 30, 2025
CureVac N.V. (CVAC) currently reports a operating income of $210M as of November 2025. That compares with $130M in the prior-year period — up 60.1% year over year. Use the charts on this page to explore CureVac N.V.'s operating income history and peer comparisons.
CureVac N.V.'s operating income increased from $130M to $210M — a 60.1% year-over-year increase (period ending November 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
CureVac N.V. reported $210M in operating income as of November 2025. That compares with $130M in the prior-year period — up 60.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current operating income of $210M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CureVac N.V., and consider following CVAC for alerts when major investors trade the stock.
CureVac N.V. is classified in the Healthcare sector. On operating income, it currently shows $210M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CVAC with unrelated industries.